S1589 Risks and Benefits of DOACS vs Warfarin in Patients With AF and Liver Disease - A Systematic Review and Meta-Analysis
Khalid A, Mautong H, Hasnol H, Njei B. S1589 Risks and Benefits of DOACS vs Warfarin in Patients With AF and Liver Disease - A Systematic Review and Meta-Analysis. The American Journal Of Gastroenterology 2023, 118: s1201-s1202. DOI: 10.14309/01.ajg.0000955996.51119.b8.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply